Oncomatryx Biopharma
Laura Murias Taboada is an experienced lab manager specializing in R&D and quality control within the biopharmaceutical and pharmaceutical industries. Currently at Oncomatryx Biopharma since March 2012, Laura has established laboratory operations, including supplier search, equipment setup, sample storage, quality method implementation, and analytical method execution. Prior roles include a quality technician position at MSD, focusing on quality system implementation and compliance with GMP standards, and a microbiology lab technician role at FAES FARMA, where responsibilities included microbial culture preparation and analysis. Additional experience includes research at UPV's neurosciences department and laboratory work in environmental analysis. Laura holds qualifications in Biotechnology, Environmental Chemistry, and Analysis and Control.
This person is not in any teams
Oncomatryx Biopharma
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma.Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumorinvasiveness, drug resistance and immunosuppression.Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy.